Feedback / Questions
ARD-101 - Aardvark Therap
https://www.renaissancecapital.com/IPO-Center/News/109217/Metabolic-disease-biotech-Aardvark-Therapeutics-sets-terms-for-$100-million
Feb 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next